Positron-emission tomography/computed tomography imaging in head and neck oncology: An update

doi:10.5319/wjo.v6.i2.23

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 6, Issue 2

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (13352)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-7) series.

Item

Count

PDF

759

WORD

492

HTML

8423

Figures (1-7)

449

Sum=10123

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1489

Download

1740

Sum=3229

May 28, 2016 (publication date) through Dec 2, 2024

Times Cited of This Article

Times Cited (3)

Journal Information of This Article

Publication Name

World Journal of Otorhinolaryngology

ISSN

2218-6247

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Otorhinolaryngol. May 28, 2016; 6(2): 23-32
Published online May 28, 2016. doi: 10.5319/wjo.v6.i2.23

Full Size Figure Download Figure

Figure 2 Occult squamous cell carcinoma of the right palatine tonsil. The lesion (green arrow) was not appreciated on physical examination, flexible endoscopy and contrast-enhanced CT (A), but demonstrated hypermetabolic activity on PET/CT with maximal SUV: 3.5 (B). Biopsy directed by PET/CT revealed squamous cell carcinoma of the right palatine tonsil. The right level IIA lymphadenopathy also showed increased FDG uptake (yellow arrow). The patient remained disease free for 5 years after treatment. PET/CT: Positron-emission tomography/computed tomography; SUV: Standardized uptake value; FDG: 2-fluoro-2-deoxy-D-glucose.

Citation: Nguyen VD, Tantiwongkosi B, Weinheimer WJ, Miller FR. Positron-emission tomography/computed tomography imaging in head and neck oncology: An update. World J Otorhinolaryngol 2016; 6(2): 23-32
URL: https://www.wjgnet.com/2218-6247/full/v6/i2/23.htm
DOI: https://dx.doi.org/10.5319/wjo.v6.i2.23